Indo US Bio-Tech (NSE:INDOUS) Debt-to-EBITDA : 0.00 (As of Dec. 2024)

Indo US Bio-Tech Debt-to-EBITDA Chart

Indo US Bio-Tech Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-EBITDA		Get a 7-Day Free Trial					2.22	2.18	1.86	1.24	1.17

Indo US Bio-Tech Quarterly Data
	Mar17	Oct17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Jun22	Sep22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Debt-to-EBITDA	Get a 7-Day Free Trial															1.44	-	2.97	0.74	-

Competitive Comparison of Indo US Bio-Tech's Debt-to-EBITDA

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo US Bio-Tech's Debt-to-EBITDA Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Debt-to-EBITDA falls into.

Indo US Bio-Tech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Indo US Bio-Tech's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Indo US Bio-Tech's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.

Indo US Bio-Tech  (NSE:INDOUS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Indo US Bio-Tech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description